We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

New Technologies Drive Hernia Repair Market

By HospiMedica International staff writers
Posted on 30 Sep 2010
Rapid adoption of biosynthetic mesh and other minimally invasive methods of hernia repair will increase revenues for manufacturers of hernia-repair specialty equipment. These are the latest findings of Kalorama Information (New York, NY, USA), an independent market research firm.

Biosynthetic mesh procedures provide benefits such as better a patient experience, greater resistance to infections and rapid tissue growth. These meshes, made up of silicone, rubber, polypropylene, or polytetrafluoroethylene (PTFE), create a protective layer that comes in contact with the intestine. Former developments include the laparoscopic repair method, widely adopted by 2000, which reduces invasiveness by patching hernias from the inside. Although once widely criticized for its high recurrence rate, continuing development of this procedure has led to a current near-zero rate of recurrence.

An important recent development is the perfection of the T-shaped prosthesis, composed of silicone and polypropylene, which reduces the development of incisional hernias, often caused by previous surgery. While the current average occurrence rate for incisional hernia cases is 15% - 20%, the use of T-shaped prosthesis is expected to reduce this figure to 3% - 4%. As a result, high-risk individuals with factors such as old age, previous surgery, obesity, and smoking, previously excluded from treatment, are expected to increase the number of hernia repair operations. In preparation, major industry players are preparing new products for this growing market.

"Biomesh and no-recurrence laparoscopy are not just small improvements, they are significant innovations,” said Bruce Carlson, the publisher of Kalorama Information. "There is a ton of innovation occurring in this market to meet the increasing demand for better quality.”

According to the Kalorama Information report, these new technologies will expand market sales to US$4.1 billion by 2012.

Related Links:
Kalorama Information


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Diagnosis Display System
C1216W
New
Transcatheter Heart Valve
SAPIEN 3 Ultra

Latest Business News

Boston Scientific Acquires Medical Device Company Intera Oncology

MEDICA 2024 to Highlight Hot Topics of MedTech Industry

Start-Ups To Once Again Play Starring Role at MEDICA 2024